Patents by Inventor Shelagh Wilson

Shelagh Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening methods using ligands of the neutropeptide receptor HFGAN72
    Patent number: 6750026
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: June 15, 2004
    Assignees: SmithKline Beecham Corporation, Board of Regents The University of Texas System
    Inventors: Derk J. Bergsma, David P. Brooks, Miklos Gellai, Shelagh Wilson, Masashi Yanagisawa
  • Polypeptide sequences of human EDG-1c
    Publication number: 20030082743
    Abstract: Human EDG-1c polypeptidees and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Human EDG-1c is identified as a selective receptor for sphingosine-1-phosphate (“S-1-P”) and for di-hydro S-1-P.
    Type: Application
    Filed: January 12, 2001
    Publication date: May 1, 2003
    Inventors: Derk J. Bergsma, Winnie Chan, Jonathan K. Chambers, Randall K. Johnson, Nassirah Khandoudi, George P. Livi, Phillipe Robert, Jeffrey M. Stadel, Pamela Joy Jensen, Shelagh Wilson
  • Screening methods using ligands of the neutropeptide receptor HFGAN72
    Publication number: 20020082202
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Application
    Filed: December 15, 2000
    Publication date: June 27, 2002
    Applicant: SmithKline Beecham Corporation
    Inventors: Derk J. Bergsma, David P. Brooks, Miklos Gellai, Shelagh Wilson, Masashi Yanagisawa
  • Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
    Patent number: 6309854
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: October 30, 2001
    Assignees: Smithkline Beecham Corporation, Board of Regents The University of Texas System
    Inventors: Derk J. Bergsma, David P. Brooks, Miklos Gellai, Shelagh Wilson, Masashi Yanagisawa